Potter Beth
Known title: CAOCIK: 0001792506
Associated companies
Transaction History
| VYX | ▼ Sell | Tax Withholding | 283 | $7K | 2/24/2023 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 444 | $12K | 2/10/2023 | View on chart |
| VYX | ▲ Buy | Option Exercise | 804 | $0 | 2/10/2023 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 285 | $8K | 2/10/2023 | View on chart |
| VYX | ▲ Buy | Option Exercise | 3,684 | $0 | 1/3/2023 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 1,109 | $26K | 1/3/2023 | View on chart |
| VYX | ▲ Buy | Grant | 2,426 | $100K | 2/25/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 377 | $16K | 2/12/2022 | View on chart |
| VYX | ▲ Buy | Option Exercise | 804 | $0 | 2/12/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 243 | $10K | 2/12/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 463 | $18K | 2/8/2022 | View on chart |
| VYX | ▲ Buy | Option Exercise | 2,939 | $0 | 2/8/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 1,037 | $40K | 2/8/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 718 | $29K | 12/31/2021 | View on chart |
| VYX | ▲ Buy | Option Exercise | 3,682 | $0 | 12/31/2021 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 1,109 | $45K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Goldman Sachs cuts NCR Voyix price target to $8
Goldman Sachs maintained a Neutral rating on NCR Voyix but lowered its price target to $8. This action follows the company's recent Q2 2026 earnings call. The new target is below the current average analyst estimate of $12.96, reflecting a cautious outlook from the firm.
Goldman Sachs cuts NCR Voyix price target to $8. Goldman Sachs maintained a Neutral rating on NCR Voyix but lowered its price target to $8. This action follows the company's recent Q2 2026 earnings call. The new target is below the current average analyst estimate of $12.96, reflecting a cautious outlook from the firm.